MedImmune and Sanofi Pasteur in LRTI Drug Pact

29.03.2017 - AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the...